Results 101 to 110 of about 5,671 (151)

A plain language summary of the results from the MAGNITUDE study assessing how effective and how safe niraparib and abiraterone acetate with prednisone is in patients with metastatic castration-resistant prostate cancer. [PDF]

open access: yesFuture Oncol
Chi KN   +19 more
europepmc   +1 more source

Erratum to "Abiraterone Acetate Attenuates SARS-CoV-2 Replication by Interfering with the Structural Nucleocapsid Protein" [Biomol Ther 30(5), 427-434 (2022)]. [PDF]

open access: yesBiomol Ther (Seoul)
Kim J   +12 more
europepmc   +1 more source

Long-Term Pharmacokinetic Follow-Up of Abiraterone Acetate in Patients with Metastatic Castration-Resistant Prostate Cancer. [PDF]

open access: yesInt J Mol Sci
Chamorey E   +14 more
europepmc   +1 more source

Real-world overall survival with abiraterone acetate versus enzalutamide in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer. [PDF]

open access: yesProstate Cancer Prostatic Dis
George DJ   +10 more
europepmc   +1 more source

Concomitant antihypertensive medication and outcome of patients with metastatic castration-resistant prostate cancer receiving enzalutamide or abiraterone acetate. [PDF]

open access: yesCancer Med
Fiala O   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy